Generated by GPT-5-mini| Foundation for Women’s Cancer | |
|---|---|
| Name | Foundation for Women’s Cancer |
| Type | Nonprofit organization |
| Founded | 1995 |
| Headquarters | United States |
| Key people | Laurel J. Rice; Margaret A. Temkin; Michael J. Birrer |
| Focus | Gynecologic oncology research, education, advocacy |
Foundation for Women’s Cancer
The Foundation for Women’s Cancer is a nonprofit organization dedicated to advancing research, education, and advocacy in gynecologic oncology. It partners with clinical centers, academic institutions, and professional societies to support investigators, clinicians, and patients affected by ovarian cancer, cervical cancer, and endometrial cancer. The foundation engages stakeholders across medical centers, philanthropic organizations, and regulatory agencies to accelerate translation of scientific discoveries into clinical care.
The Foundation for Women’s Cancer traces its origins to collaborations among leaders at Memorial Sloan Kettering Cancer Center, Johns Hopkins Hospital, Mayo Clinic, and Dana-Farber Cancer Institute in the mid-1990s, with influence from clinicians affiliated with Brigham and Women's Hospital, Massachusetts General Hospital, Stanford Hospital, and UCLA Medical Center. Early supporters included philanthropists connected to The Rockefeller Foundation and advocates associated with survivor networks like those influenced by campaigns at Susan G. Komen for the Cure. The foundation’s development paralleled initiatives led by research funders such as the National Cancer Institute, American Cancer Society, and programs at National Institutes of Health centers, aligning with clinical trial infrastructures like the Gynecologic Oncology Group and cooperative groups tied to Medical Research Council (United Kingdom). Throughout its history the foundation has intersected with policy discussions involving Food and Drug Administration, guideline-producing bodies such as American Society of Clinical Oncology, and professional associations like Society of Gynecologic Oncology and American College of Obstetricians and Gynecologists.
The foundation’s mission emphasizes funding translational science and training clinician-scientists at institutions including Harvard Medical School, Yale School of Medicine, Columbia University Irving Medical Center, University of Pennsylvania Health System, and University of California, San Francisco. Programmatic efforts mirror initiatives seen at Wellcome Trust, Bill & Melinda Gates Foundation, and academic programs at Weill Cornell Medicine by offering fellowships, career development awards, and research symposia comparable to conferences hosted by American Association for Cancer Research, European Society for Medical Oncology, and the American Society of Clinical Oncology. Educational activities coordinate speakers from centers such as Cleveland Clinic, Johns Hopkins Bloomberg School of Public Health, and Icahn School of Medicine at Mount Sinai to address clinical care, surgical techniques refined at Memorial Sloan Kettering Cancer Center, and molecular oncology approaches promoted at Cold Spring Harbor Laboratory.
Research funding targets investigators at institutions like Fred Hutchinson Cancer Research Center, Sloan Kettering Institute, Broad Institute, and Scripps Research with grant mechanisms similar to those from Howard Hughes Medical Institute and foundation-supported awards at Chan Zuckerberg Initiative. Grants support biomarker discovery, genomic studies using resources akin to The Cancer Genome Atlas, and translational trials conducted alongside cooperative networks such as National Comprehensive Cancer Network member sites. The foundation has funded projects involving targeted therapy research linked to approvals by European Medicines Agency and trials coordinated with groups like Translational Research Network and academic consortia at University of Michigan Health System and Johns Hopkins Kimmel Cancer Center.
Education programs target clinicians, trainees, and patient advocates connected to organizations such as American Cancer Society, Patient-Centered Outcomes Research Institute, and advocacy networks like Breast Cancer Research Foundation affiliates and community groups in partnership with March of Dimes chapters. Advocacy priorities have intersected with legislative efforts addressed by offices represented in United States Congress, regulatory processes at Food and Drug Administration, and policy forums hosted by World Health Organization and Centers for Disease Control and Prevention. Training initiatives have included workshops with faculty from University of California, Los Angeles, Northwestern University Feinberg School of Medicine, and University of Texas MD Anderson Cancer Center.
Fundraising strategies deploy collaborations with philanthropic entities such as Bill & Melinda Gates Foundation, The Rockefeller Foundation, and family foundations modeled after Wallace Alexander Gerbode Foundation, while corporate partnerships have involved biotechnology firms and medical device companies similar to those engaged with Pfizer, Genentech, and Roche. The foundation has convened benefit events hosted alongside cultural institutions like Lincoln Center and sports partnerships reminiscent of fundraising ties with franchises such as New York Yankees and Los Angeles Lakers charity programs. Strategic alliances include collaborations with academic consortia, industry sponsors at major conferences such as ASCO Annual Meeting and ESMO Congress, and philanthropic coalitions like Giving Tuesday campaigns.
Governance comprises a volunteer board with leaders drawn from institutions such as Harvard Medical School, Yale School of Medicine, University of Pennsylvania, Columbia University, and Stanford University School of Medicine, alongside scientific advisors with appointments at Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, and Mayo Clinic. Operational leadership works with legal counsel and finance committees familiar with nonprofit compliance frameworks and reporting practices seen in organizations like Council on Foundations and Independent Sector. The foundation’s advisory panels include representatives from academic consortia, patient advocacy groups, and funding bodies comparable to National Institutes of Health program officers and grant review committees at American Board of Obstetrics and Gynecology.
Category:Medical and health foundations